Half dose verteporfin PDT for central serous chorioretinopathy

British Journal of Ophthalmology

Volumn 90, Issue 7, 2006, Pages 805-806

  Stewart, Jay M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS ACTING ON THE EYE; STEROID; UNCLASSIFIED DRUG; VERTEPROFIN;

CENTRAL SEROUS RETINOPATHY; CHOROID CAPILLARY LAYER; CHOROID DISEASE; CLINICAL OBSERVATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEMANGIOMA; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INFUSION RATE; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PIGMENT DISORDER; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY;

CHORIORETINITIS; DRUG ADMINISTRATION SCHEDULE; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 33745670151     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.093328     Document Type: Editorial

References (9)

1. Chan WM, Lam DSC, Lai TYY, et al. Choroidal vascular remodeling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-8.
2. Taban M, Boyer DS, Thomas EL, et al. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004;137:1073-80.
3. Yanuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy. Retina 2003;23:288-98.
4. Piccolino FC, Eandi CM, Ventre L, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina 2003;23:752-63.
5. Lai T Y Y, Chan W-M, Li H, et al. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol 2006;90:869-74.
6. Michels S, Michels R, Simader C, et al. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina 2005;25:697-703.
7. Verbraak FD, Schlingemann RO, de Smet MD, et al. Single spot PDT in patients with circumscribed choroidal haemangioma and near normal visual acuity. Graefes Arch Clin Experiment Ophthalmol, 2006; Feb 28 (e-pub ahead of print).
8. Michels S, Hansmann F, Geitzenauer W, et al. Influence of treatment parameters on selectivity of verteporfin therapy. Invest Ophthalmol Vis Sci 2006;47:371-6.
9. Visudyne in Minimally Classic Choroidal Neovascularization Study Group. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 2005;123:448-57.